Bcal Diagnostics Limited

BDX

BCAL Diagnostics Ltd. develops screening tests for the early detection of breast cancer. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-07-21. The Company’s principal activities include the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, including preparation for clinical trials. The company developed a blood screening test to be used alongside breast cancer screening methods. The technology initially complements imaging technologies, such as the mammogram, while it further progresses the development of a monitoring and screening test suitable for women of all ages and backgrounds in any location. Its BCAL test is a lipid biomarker blood (Breast Cancer Associated Lipids test) test with the potential to be used for breast cancer prevention, screening, and monitoring. The firm has partnered with Precion Inc. to optimize protocols and procedures for the clinical studies required for regulatory approvals across several jurisdictions.

Birddog Technology Limited

BDT

BirdDog Technology Ltd. develops and manufactures audio-visual and video technology. The principal activities of the Company consist of development and manufacturing of global video technology that enhances the quality, speed and flexibility of video through a range of solutions, augmented with network device interface (NDI). These solutions are then sold through a network of distributors and resellers and direct, to individuals and organizations within professional video, corporate audio-visual (AV) and digital signage markets who demand broadcast quality video content. NDI uses software, computers and networks to make video creation and sharing accessible. The Company’s NDI Bridge transports complete NDI streams over local area network (LAN), wide area network (WAN) or public Internet. Its NDI Audio Direct makes audio-over-IP available for software-based audio applications.